MONDAY, Sept. 20, 2021 (HealthDay News) — Pregnant women infected with certain strains of human papillomavirus (HPV) may have a heightened risk of preterm birth, a new study suggests. HPV is a sexually transmitted disease that can cause genital warts. Most of the time, the immune system clears the infection.Continue Reading

MONDAY, Sept. 20, 2021 (HealthDay News) — A study of millions of people vaccinated against COVID-19 has identified those at greatest risk of hospitalization and death after breakthrough infection. The most vulnerable are those who are immunosuppressed from chemotherapy, a recent bone marrow or solid organ transplant, or HIV/AIDS. AlsoContinue Reading

FRIDAY, Sept. 17, 2021 (HealthDay News) — An advisory panel to the U.S. Food and Drug Administration on Friday recommended a third Pfizer-BioNTech COVID vaccine booster shot for all Americans aged 65 or older, as well as for those deemed to be at high risk for severe illness. According toContinue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — The cost of providing hospital care for unvaccinated Americans has reached $5.7 billion in just three months, CBS News reported. Between June and August, about 287,000 people who were not vaccinated were hospitalized for COVID-19 in the United States, according to data fromContinue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — The number of U.S. infants born with syphilis is climbing at an alarming pace, reaching a high not seen since the 1990s, according to new government figures. Newborn syphilis, a potentially fatal condition, was at one time nearly eliminated in the United States.Continue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — As severe cases of COVID-19 rise and demand surges for monoclonal antibody treatments, the U.S. government is ordering more from two key suppliers. Monoclonal antibodies, which are lab-engineered immune system proteins, can help trigger a healthy immune response against COVID-19 infection. The BidenContinue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — Multiple sclerosis (MS) patients undergoing a treatment that depletes a type of immune cell that fuels MS attacks still have a strong response to mRNA COVID-19 vaccines, a new study finds. “The message from this study is clear — it is worthwhile forContinue Reading